Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 126,339,124 shares of Common Stock outstanding as of January 30, 2026, as reported in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on February 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 126,339,124 shares of Common Stock outstanding as of January 30, 2026, as reported in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on February 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 126,339,124 shares of Common Stock outstanding as of January 30, 2026, as reported in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on February 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 126,339,124 shares of Common Stock outstanding as of January 30, 2026, as reported in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on February 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 126,339,124 shares of Common Stock outstanding as of January 30, 2026, as reported in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on February 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 126,339,124 shares of Common Stock outstanding as of January 30, 2026, as reported in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on February 3, 2026.


SCHEDULE 13G



 
CRCM LP
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM LP
Date:02/12/2026
 
CRCM LLC
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM LLC
Date:02/12/2026
 
CRCM INSTITUTIONAL MASTER FUND (BVI), LTD.
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM INSTITUTIONAL MASTER FUND (BVI), LTD.
Date:02/12/2026
 
CRCM B SPV, LP
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM B SPV, LP
Date:02/12/2026
 
CRCM Fintech Fund, LP
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM Fintech Fund, LP
Date:02/12/2026
 
Ding Chun R
 
Signature:/s/ Chun R. Ding
Name/Title:DING CHUN R
Date:02/12/2026
Exhibit Information

Exhibit 1 -- Joint Acquisition Statement Pursuant to Section 240.13d-1(k)